MedTrace Logo

Autologous Regeneration of Tissue (ART) for Wound Healing

NCT03796988 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2025-04-23

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to learn about a new device, Autologous Regeneration of Tissue (ART), for collecting skin grafts from participant's own skin.

Conditions

  • Wound of Skin

Interventions

DEVICE

Autologous Regeneration of Tissue (ART) device

This device will harvest hundreds of full-thickness columns of skin tissue (500 micrometer diameter) using single-needle, fluid-assisted harvesting technology.

Sponsors & Collaborators

  • Medline Industries

    collaborator INDUSTRY

  • University of Miami

    lead OTHER

Principal Investigators

  • Hadar Lev-Tov, MD · University of Miami

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-14
Primary Completion
2024-03-19
Completion
2024-03-19
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03796988 on ClinicalTrials.gov